A study in patient satisfaction regarding telemedicine consultations in radiation oncology

INTRODUCTION: Telemedicine consultations can be a cost‐effective and convenient method of communication, particularly with patients living in remote areas. Given the dearth of patient‐reported satisfaction data with this form of consultation in Radiation Oncology, we surveyed patients to assess this in our department. METHODS: The study recruited patients who had experienced both a Telemedicine consultation and an in‐person consultation with the same radiation oncologist at our tertiary centre in South Australia. Eligible patients were identified from the Royal Adelaide Hospital oncology information system. The patient satisfaction questionnaire was sent via registered post with a reply‐paid envelope. The questionnaire consisted of 38 questions divided into four major categories, focusing on communication, medical care, privacy/confidentiality and convenience. Results of the survey were tabulated in an excel spreadsheet. RESULTS: Between 1 January 2018 and 1 January 2019, 130 eligible patients were identified. One hundred and nine patients were alive and contactable of whom 37 responded (34%). Two surveys were returned incomplete resulting in 35 patient responses available for analysis. The median age was 70 years (range 35–87); 74% were male. There was no statistically significant difference between the satisfaction scores for Telemedicine and in‐person consultations with regards to communication, privacy/confidentiality or overall satisfaction. The respondent felt it was more important to be examined when the consultation was conducted in‐person and found Telemedicine consultations more convenient in terms of cost and time. CONCLUSION: Telemedicine used in Radiation Oncology is an effective form of consultation that is convenient, provides a similar level of patient satisfaction and maintains patient confidentiality. Telemedicine consultations should therefore be considered for all rural and remote cancer patients where feasible.